Clinical trial
Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of…
NCT01586910 · Medtronic Cardiovascular, Industry · Active, not recruiting
Key facts
| NCT number | NCT01586910 |
|---|---|
| Title | Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI). |
| Official title | Surgical Replacement and Transcatheter Aortic Valve Implantation (SURTAVI) |
| Acronym | SURTAVI |
| Lead sponsor | Medtronic Cardiovascular, Industry |
| Status | Active, not recruiting |
| Study type | Interventional |
| Conditions | Severe Aortic Stenosis |
| Intervention type | Device, Procedure |
| Interventions | Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI), Surgical Aortic Valve Replacement (SAVR), Medtronic CoreValve® Evolut R System Transcatheter Aortic Valve Implantation (TAVI) |
| Enrollment | 1,746 |
| Start date | Apr 1, 2012 |
| Primary completion | Jul 1, 2018 |
| Completion | Nov 1, 2026 |
| First posted | Apr 27, 2012 |
| Last update posted | Oct 28, 2025 |
| Countries | Canada, Denmark, Germany, Netherlands, Spain, Sweden, Switzerland, United Kingdom, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: